Ikena Oncology, Inc. (IKNA) has 4 open-market insider trades by 4 insiders since 2021. The most active filer is David P. Bonita, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| David P. Bonita | Dir | — | 1 | $6.8M | 2023-08-04 |
| Jean Francois Formela | Dir | — | 1 | $2.7M | 2021-12-14 |
| Atlas Venture Associates Opportunity I, LLC | 10% Owner | — | 1 | $302K | 2021-12-13 |
| Xiaoyan Michelle Zhang | Chief Scientific Officer | — | 1 | $15K | 2022-01-11 |
| OrbiMed Genesis GP LLC | Dir | — | 0 | — | 2021-03-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David P. Bonita | Director | Buy | $1.1M | 2022-06-22 |
| Xiaoyan Michelle Zhang | Chief Scientific Officer | Sell | $12K | 2022-01-10 |
| Jean Francois Formela | Director | Sell | $688K | 2021-12-10 |
| Atlas Venture Associates Opportunity I, LLC | 10% | Sell | $302K | 2021-12-10 |
| Xiaoyan Michelle Zhang | Chief Scientific Officer | Sell | $15K | 2021-12-10 |
| David P. Bonita | Director | Buy | $6.8M |
Companies that share insiders with IKNA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-03-30 |
| Jean Francois Formela | Director | Buy | $2.0M | 2021-03-30 |